GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xlife Sciences AG (CHIX:XLSz) » Definitions » COGS-to-Revenue

Xlife Sciences AG (CHIX:XLSZ) COGS-to-Revenue : 0.49 (As of Dec. 2023)


View and export this data going back to 2024. Start your Free Trial

What is Xlife Sciences AG COGS-to-Revenue?

Xlife Sciences AG's Cost of Goods Sold for the three months ended in Dec. 2023 was CHF0.31 Mil. Its Revenue for the three months ended in Dec. 2023 was CHF0.64 Mil.

Xlife Sciences AG's COGS to Revenue for the three months ended in Dec. 2023 was 0.49.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Xlife Sciences AG's Gross Margin % for the three months ended in Dec. 2023 was 50.94%.


Xlife Sciences AG COGS-to-Revenue Historical Data

The historical data trend for Xlife Sciences AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xlife Sciences AG COGS-to-Revenue Chart

Xlife Sciences AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial 0.65 1.07 0.55 0.82 0.55

Xlife Sciences AG Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.98 0.73 0.65 0.49

Xlife Sciences AG COGS-to-Revenue Calculation

Xlife Sciences AG's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.539 / 0.988
=0.55

Xlife Sciences AG's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.314 / 0.64
=0.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xlife Sciences AG  (CHIX:XLSz) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Xlife Sciences AG's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.314 / 0.64
=50.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Xlife Sciences AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Xlife Sciences AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Xlife Sciences AG (CHIX:XLSZ) Business Description

Comparable Companies
Traded in Other Exchanges
Address
Talacker 35, Zürich, CHE, 8001
Xlife Sciences AG is a Swiss company with a focus on performance technologies in life sciences. The company allows its investors a very early and direct Entry into the further development of innovative and future-oriented technologies.

Xlife Sciences AG (CHIX:XLSZ) Headlines

No Headlines